About
Coherent Biopharma develops proprietary Bi-targeting XDC (conjugate) technology to create drug candidates addressing unmet medical needs primarily in oncology and other diseases.
Explore Coherent Biopharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.